Parametric mapping of contrasted ovarian transvaginal sonography
- PMID: 26002525
- PMCID: PMC4443867
- DOI: 10.1097/RUQ.0000000000000125
Parametric mapping of contrasted ovarian transvaginal sonography
Abstract
The purpose of this study was to assess the accuracy of parametric analysis of transvaginal contrast-enhanced ultrasound (TV-CEUS) for distinguishing benign versus malignant ovarian masses. A total of 48 ovarian masses (37 benign and 11 borderline/malignant) were examined with TV-CEUS (Definity; Lantheus, North Billerica, MA; Philips iU22; Philips Medical Systems, Bothell, WA). Parametric images were created offline with a quantification software (Bracco Suisse SA, Geneva, Switzerland) with map color scales adjusted such that abnormal hemodynamics were represented by the color red and the presence of any red color could be used to differentiate benign and malignant tumors. Using these map color scales, low values of the perfusion parameter were coded in blue, and intermediate values of the perfusion parameter were coded in yellow. Additionally, for each individual color (red, blue, or yellow), a darker shade of that color indicated a higher intensity value. Our study found that the parametric mapping method was considerably more sensitive than standard region of interest (ROI) analysis for the detection of malignant tumors but was also less specific than standard ROI analysis. Parametric mapping allows for stricter cutoff criteria, as hemodynamics are visualized on a finer scale than ROI analyses, and as such, parametric maps are a useful addition to TV-CEUS analysis by allowing ROIs to be limited to areas of the highest malignant potential.
Figures






Similar articles
-
Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings.J Ultrasound Med. 2008 Jul;27(7):1011-8; quiz 1019-21. doi: 10.7863/jum.2008.27.7.1011. J Ultrasound Med. 2008. PMID: 18577664
-
Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography.J Ultrasound Med. 2009 Oct;28(10):1273-80. doi: 10.7863/jum.2009.28.10.1273. J Ultrasound Med. 2009. PMID: 19778872
-
[Value of color Doppler ultrasonography, contrast-enhanced ultrasound and serum CA-125 detection in differential diagnosis of ovarian masses].Nan Fang Yi Ke Da Xue Xue Bao. 2009 Oct;29(10):2007-9. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19861251 Chinese.
-
An overview of the development and application of the sonographic scoring system: differentiation of malignant from benign ovarian tumors.Arch Gynecol Obstet. 2016 Feb;293(2):303-10. doi: 10.1007/s00404-015-3957-x. Epub 2015 Nov 17. Arch Gynecol Obstet. 2016. PMID: 26576768 Review.
-
Controversies in assessment of ovarian tumors with transvaginal color Doppler ultrasound.Acta Obstet Gynecol Scand. 1996 Apr;75(4):316-29. doi: 10.3109/00016349609033324. Acta Obstet Gynecol Scand. 1996. PMID: 8638449 Review.
Cited by
-
Comparison of tumor angiogenesis in subcutaneous and orthotopic LNCaP mouse models using contrast-enhanced ultrasound imaging.Transl Cancer Res. 2021 Jul;10(7):3268-3277. doi: 10.21037/tcr-21-372. Transl Cancer Res. 2021. PMID: 35116633 Free PMC article.
-
Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.Medicine (Baltimore). 2018 Apr;97(16):e0358. doi: 10.1097/MD.0000000000010358. Medicine (Baltimore). 2018. PMID: 29668586 Free PMC article.
References
-
- Jinawath N, Shih I. Biology and pathology of ovarian cancer. In: Briston R, Armstrong D, editors. Early Diagnosis and Treatment of Cancer. Ovarian Cancer. Philadelphia, Pa, USA: Saunders; 2011. pp. 17–32.
-
- Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52(1):2347. - PubMed
-
- Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol. 2007;8(9):773–783. - PubMed
-
- Engel J, Eckel R, Schubert-Fritschle G, et al. Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer. 2002;38(18):2435–2445. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical